Kunyu Yang, Xiaomeng Zhang, Lu Wen. "Neoadjuvant ivonescimab (AK112, a PD-1/VEGF bispecific antibody) combined with nab-paclitaxel and cisplatin (AP) for resectable locally advanced head and neck squamous cell carcinoma (LA-HNSCC): An exploratory phase II study.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.6014